Pearlman, Ross L.
Nahar, Vinayak K.
Sisson, William T.
Clark, Josh
Ferris, Taylor S.
Black, William H.
Brodell, Robert T.
Article History
Received: 1 April 2022
Revised: 27 September 2022
Accepted: 13 October 2022
First Online: 21 November 2022
Declarations
:
: Ross L. Pearlman has accepted grant funding from the American Academy of Dermatology (AAD) and served on an advisory board for Castle Biosciences. Robert T. Brodell is a principal investigator for a clinical trial (Novartis) and for the Corevitas psoriasis biologic registry. He has stock in Veradermics, Inc. Vinayak K. Nahar, Taylor S. Ferris, William T. Sisson, and William H. Black have no conflicts of interest.
Free to read: This content has been made available to all.